Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
Clinical Pharmacology: Advances and Applications · 2016
DOI: 10.2147/cpaa.s102676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Virendra Rambiritch und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of KwaZulu-Natal, Durban. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of KwaZulu-Natal, Durban.
- Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa.
- Novartis Pharma AG, Basel, Switzerland.
Zitieren
APA
Rambiritch, V., Naidoo, P., Maharaj, B., & Pillai, G. (2016). Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s102676
Vancouver
Rambiritch V, Naidoo P, Maharaj B, Pillai G. Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s102676
BibTeX
@article{Rambiritch2016,
author = {Rambiritch, Virendra and Naidoo, Poobalan and Maharaj, Breminand and Pillai, Goonaseelan},
title = {Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2016},
doi = {10.2147/cpaa.s102676}
}
EUVIMED